Humanigen, Inc. (OTCQB: HGEN) is a biopharmaceutical company pursuing cutting-edge science to develop our proprietary monoclonal antibodies for immunotherapy and oncology treatments. Joining our podcast today is Cameron Durrant, Chairman and CEO.